Ftse Mib
33.881,50
0,74%
DAX
17.837,40
0,28%
S&P 500
5.011,12
-0,22%
NASDAQ Composite
15.601,50
-0,52%
Bitcoin
60.440,00
-4,81%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Assistente personale
Home Investire Azioni Europa EU Mithra Pharmaceuticals SA (MITRA) Mithra Pharmaceuticals SA (MITRA) Notizie

Mithra Pharmaceuticals SA

MITRA
0,233
0,0125 (5,67%)
19 Apr 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: Euronext
Tipo: Azione Ordinaria
Valuta: EUR

Ultime notizie

Data Ora Fonte Titolo
08/3/202407:00GLOBEMithra reports full year 2023 financial results
05/3/202407:01GLOBEMithra announces changes to its executive management
05/3/202407:00GLOBEMithra initiates monetization process, receives bridge loan..
29/2/202411:42GLOBEDONESTA® safety study for menopause completes treatment..
15/2/202418:23GLOBEMithra sells shares in Mayne Pharma
06/2/202407:00GLOBEMithra updates on cash position
21/12/202317:45GLOBEMithra and Rafa Laboratories sign binding Head of Terms to..
20/12/202317:45GLOBEMithra Completes Pediatric Study of ESTELLE® in Adolescent..
18/12/202307:00GLOBEMithra Receives Positive DSMB Opinion on DONESTA® European..
04/12/202307:00GLOBEMithra and Gedeon Richter sign binding Head of Terms to..
30/11/202307:00GLOBEMithra receives guidance from the FDA for the DONESTA® NDA..
28/11/202317:45GLOBEMithra to hold five presentations on key role of estrogens..
07/11/202307:00GLOBEMithra’s NEXTSTELLIS® granted additional patent in the..
06/11/202318:52GLOBEMithra releases invitation to its extraordinary securities..
26/10/202307:00GLOBEMithra and Searchlight Pharma sign DONESTA® licensing..
23/10/202307:00GLOBEMithra to receive EUR 2.5 million milestone payment from..
17/10/202307:00GLOBEMithra’s Board of Directors to propose the removal of its..
11/10/202307:15GLOBEShareholder Letter
11/10/202307:00GLOBEMithra announces update to the agenda of its upcoming..
10/10/202318:00GLOBEMithra to Hold Presentations on Key Role of Estrogens in..
05/10/202307:00GLOBEMithra Provides an Update in the Context of Recent Market..
27/9/202307:00GLOBEMithra Announces Presentation of Positive Data on Estetrol..
26/9/202307:00GLOBEMithra Financial Results for First-Half 2023
22/9/202313:30GLOBEMithra présentera ses résultats financiers du premier..
21/9/202317:55GLOBEMithra to Hold Investor Call on H1 2023 Financial Results on..
12/9/202317:45GLOBENotice of Adjustment of the Conversion Price of Mithra's EUR..
11/9/202307:30GLOBELetter to Shareholders and Corporate Update
28/8/202317:45GLOBEMithra completes EUR 20 million private placement in equity..
24/8/202307:33GLOBEMithra prices private placement to raise EUR 20 million in..
08/8/202307:30GLOBEMithra and Gedeon Richter Sign Supply Agreement for..
03/8/202307:30GLOBEMithra Receives EUR 1.25 Million Milestone Payment from Fuji..
31/7/202307:30GLOBEMithra and Searchlight Pharma Announce Donesta® Licensing..
17/7/202317:45GLOBENotice of Adjustment of the Conversion Price of Mithra's..
04/7/202317:45GLOBENotice of Adjustment of the Conversion Price of Mithra's EUR..
26/6/202317:45GLOBEMithra Announces Information on the Total Number of Voting..
21/6/202320:38GLOBEMithra has access to the new EUR 12.5 million tranche of the..
15/6/202307:30GLOBEMithra Announces New Positive Preclinical Data from CSF-1R..
05/6/202317:45GLOBEMithra - Publication of a transparency notification received..
29/5/202307:30GLOBEMithra Appoints Experienced Life Sciences Executive..
25/5/202318:39GLOBEMithra’s General Meeting Of Shareholders Approves the..
25/5/202317:45GLOBEMithra’s General Meeting Of Shareholders Approves the..
25/5/202307:30GLOBEMithra - Letter to Shareholders and Corporate Update
12/5/202317:45GLOBEMithra Pharmaceuticals - Payment of the interests of the..
11/5/202307:30GLOBEMithra Announces Completion of Recruitment in Pediatric..
04/5/202307:30GLOBEMithra and the University of Liège Secure Proof-of-Concept..
28/4/202317:45GLOBEPublication of a transparency notification received from..
25/4/202307:30GLOBEMithra Releases Invitation to its General Shareholders’..
Apertura: 0,2235 Min: 0,221 Max: 0,2335
Chiusura: 0,2205

La tua Cronologia

EU
MITRA
Mithra Pharmaceuticals
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network